3 ungewöhnliche Verläufe von gastrointestinalen MALT-Lymphomen

Zusammenfassung

Wir berichten über den ungewöhnlichen Krankheitsverlauf von drei Patienten mit gastro-intestinalen MALT-Lymphomen. Besonderheiten sind die primäre Manifestation der Lymphome, die hochmaligne Transformation im weiteren Verlauf, der lange Zeitraum zwischen initial erfolgreicher kurativ intendierter Therapie und dem Rezidiv und das Auftreten einer weiteren Neoplasie in einem Fall. Dies zeigt, dass trotz der allgemein guten Prognose von gastrointestinalen MALT-Lymphomen Nachsorgeuntersuchungen sinnvoll sind.

Abstract

We report on the unusual course of disease in three patients with gastrointestinal MALT lymphoma. Special features are the primary lymphoma manifestation, the high-grade transformation during the follow up, the long-time interval between initially curative intended therapy and relapse and the occurrence of another neoplasia in one case. This demonstrates that despite their good prognosis in general, follow-up investigations of gastrointestinal MALT lymphoma are reasonable.

Schlüsselwörter

MALT-Lymphom - gastrointestinal - Lokalisation - Krankheitsverlauf - hochmaligne Transformation

Key words

MALT lymphoma - gastrointestinal - localization - course of disease - high-grade transformation

Publication History

Article published online:
30 August 2021

• Literatur

• 1 Wündisch T, Dieckhoff P, Greene B. et al. Second cancers and Residual Disease in Patients Treated for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma by Helicobacter pylori Eradication and Followed for 10 Years. Gastroenterology 2012; 143: 936-942
• 2 Fischbach W, Dragosics B, Koelve-Goebeler ME. et al. Primary gastric B-cell Lymphoma: Results of a Prospective Multicenter Study. Gastroenterology 2000; 119: 1191-1202
• 3 Ruskoné-Fourmestraux A, Fischbach W, Aleman BMP. et al. EGILS consensus report.Gastric extranodal marginal zone B cell lymphoma of MALT. Gut 2011; 60: 747-758
• 4 Fischbach W, Malfertheiner P, Lynen Jansen P. et al. S2k Leitlinie H. pylori und gastroduo-denale Ulkuskrankheit. Z Gastroenterol 2016; 54: 327-363
• 5 Fischbach W, Goebeler-Kolve ME, Dragosics B. et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication: experience from a large prospective series. GUT 2004; 53: 34-37
• 6 Zullo A, Hassan C, Cristofari F. et al. Effects of Helicobacter pylori Eradication on Early Stage Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Clin Gastroenterol Hepatol 2010; 8: 105-110
• 7 Fischbach W, Goebeler ME, Ruskone-Fourmestraux A. et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be safely managed by a watch-and-wait strategy. Experience from a large international series. Gut 2007; 56: 1685-1687
• 8 Fischbach W, Dorlöchter C. Patients with gastric MALT lymphoma revealing persisting endoscopic abnormalities after successful eradication of Helicobacter pylori can be safely managed by a watch-and-wait strategy. Z Gastroenterol 2019; 57: 593-599
• 9 Eck M, Schmaußer W, Haas R. et al. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 1997; 112: 1482-1486
• 10 Al-Taie O, Al-Taie E, Fischbach W. Patienten mit Helicobacter-pylori negativen gastralen Marginalzonen-B-Zell-Lymphomen (MZBZL) des MALT haben eine gute Prognose. Z Gastroenterol 2014; 52: 1389-1393
• 11 Fischbach W. Colorectal MALT lymphoma: a rare clinical entity. Z Gastroenterol 2018; 56: 905-911
• 12 Capelle LG, de Vries AC, Looman CWN. et al. Gastric MALT lymphoma: Epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer 2008; 44: 2470-2476
• 13 Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 1998; 16: 916-1921
• 14 Tsang RW, Gospodarowicz MK, Pintilie M. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003; 21: 4157-4164
• 15 Koch P, Probst A, Berdel WE. et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol 2005; 23: 7050-7059
• 16 Fischbach W, Schramm S, Goebeler E. Outcome and quality of life favour a conservative treatment of patients with primary gastric lymphoma. Z Gastroenterol 2011; 49: 430-435